CARLUCCIO, Erberto
 Distribuzione geografica
Continente #
NA - Nord America 2.881
AS - Asia 2.584
EU - Europa 2.171
SA - Sud America 473
AF - Africa 61
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 8.177
Nazione #
US - Stati Uniti d'America 2.810
SG - Singapore 1.196
HK - Hong Kong 385
BR - Brasile 361
IE - Irlanda 344
IT - Italia 344
RU - Federazione Russa 337
CN - Cina 331
VN - Vietnam 240
SE - Svezia 235
UA - Ucraina 226
FR - Francia 185
DE - Germania 155
KR - Corea 125
FI - Finlandia 97
GB - Regno Unito 66
IN - India 61
BD - Bangladesh 45
AR - Argentina 43
BE - Belgio 37
AT - Austria 33
CA - Canada 29
NL - Olanda 29
PL - Polonia 26
IQ - Iraq 25
TR - Turchia 24
ZA - Sudafrica 21
MX - Messico 20
ID - Indonesia 19
VE - Venezuela 17
CH - Svizzera 16
UZ - Uzbekistan 16
JP - Giappone 15
CO - Colombia 14
MY - Malesia 13
PK - Pakistan 13
SA - Arabia Saudita 13
ES - Italia 12
MA - Marocco 11
CL - Cile 10
EC - Ecuador 10
JO - Giordania 9
PH - Filippine 9
LB - Libano 7
PY - Paraguay 7
EG - Egitto 6
IL - Israele 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
KE - Kenya 5
LT - Lituania 5
PE - Perù 5
SY - Repubblica araba siriana 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
EU - Europa 4
NP - Nepal 4
PT - Portogallo 4
AZ - Azerbaigian 3
BO - Bolivia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BB - Barbados 2
DZ - Algeria 2
KH - Cambogia 2
KW - Kuwait 2
LY - Libia 2
MZ - Mozambico 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
TL - Timor Orientale 2
UY - Uruguay 2
YE - Yemen 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
TG - Togo 1
Totale 8.174
Città #
Singapore 823
Chandler 426
Hong Kong 384
Dublin 334
San Jose 273
Ashburn 186
San Mateo 172
Boardman 141
Perugia 120
Santa Clara 120
Seoul 120
Jacksonville 113
Moscow 108
Lauterbourg 101
Dong Ket 92
Beijing 90
Altamura 79
Medford 78
Princeton 78
Lawrence 64
Wilmington 60
Ann Arbor 58
Los Angeles 58
Andover 56
The Dalles 56
Piscataway 51
New York 49
Ho Chi Minh City 43
Saint Petersburg 42
Helsinki 38
Brussels 36
Munich 34
São Paulo 33
Nuremberg 26
Hanoi 25
Amsterdam 19
Dallas 19
Woodbridge 19
Frankfurt am Main 18
Warsaw 18
Hefei 16
Orem 16
Denver 15
Falls Church 14
Rio de Janeiro 14
Chicago 12
Des Moines 12
Norwalk 12
Tokyo 12
Baghdad 11
Brooklyn 11
Houston 11
Redwood City 11
Belo Horizonte 10
Chennai 10
Da Nang 10
Falkenstein 10
Guangzhou 10
Lappeenranta 10
Montreal 10
Shanghai 10
Council Bluffs 9
Florence 9
Johannesburg 9
Manchester 9
Milan 9
Rome 9
Tashkent 9
Vienna 9
Amman 8
Atlanta 8
Boston 8
Dhaka 8
London 8
San Paolo di Civitate 8
Stockholm 8
Ankara 7
Biên Hòa 7
Turku 7
Curitiba 6
Frankfurt Am Main 6
Genoa 6
Haiphong 6
Lausanne 6
Phoenix 6
San Francisco 6
Santo André 6
Toronto 6
Bogotá 5
Brasília 5
Buenos Aires 5
Bắc Giang 5
Campinas 5
Cotia 5
Fortaleza 5
Jeddah 5
Kuala Lumpur 5
Menlo Park 5
Nairobi 5
Ribeirão Preto 5
Totale 5.170
Nome #
Atrial fibrillation in hypertension: predictors and outcome 157
Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. 136
Relationship between contractile reserve and diastolic function in hibernating myocardium 120
[Dyslipidemia as cardiovascular and cerebrovascular risk factor: epidemiology and physiopathology] 115
Atrial Function in Patients Undergoing CRT REPLY 115
Apoptosi: come si può controllare la morte cellulare programmata e che benefici possiamo attenderci sul cuore? 113
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction 111
Arresto cardiaco ipocinetico ed ipereosinofilia: sindrome di Kounis o sindrome di Churg-Strauss? 109
Blood pressure variability: relation with sex and age. 107
Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study 106
Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction 105
Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. 104
Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure 104
Prognostic Value of Right Ventricular Dysfunction in Heart Failure With Reduced Ejection Fraction: Superiority of Longitudinal Strain Over Tricuspid Annular Plane Systolic Excursion 103
Superior Prognostic Value of Right Ventricular Free Wall Compared to Global Longitudinal Strain in Patients With Heart Failure 103
Impact of metabolic syndrome on presentation and evolution of acute coronary syndromes 102
C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. 101
Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: A multicenter cohort analysis 99
Advantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fraction. 98
Role of endothelial dysfunction in heart failure 98
Left Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection Fraction 97
Long term follow up of acute coronary syndromes in patients with metabolic syndrome: differences between stemi vs nstemi 96
Improved cardiovascular risk stratification by a simple ECG index in hypertension 96
Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis 96
Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failure 93
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 93
Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction 92
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 92
La fibrinolisi nella terapia dell'infarto acuto del miocardio. Dai grandi trials alla pratica clinica: Risultati dell'U.O. di Cardiologia del Policlinico Monteluce di Perugia su 1151 pazienti consecutivi 91
Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients 91
Effects of Metabolic Syndrome on Pattern of Acute Coronary Syndromes 90
Fattori che influenzano la presentazione elettrocardiografica e l'evoluzione clinica delle sindromi coronariche acute. 89
Effects of acute myocardial ischemia on QT dispersion by dipyridamole-stress echocardiography 88
Gestione computerizzata del paziente sottoposto ad ecocardiografia con stress farmacologico 86
Exercise-induced B-lines in heart failure with preserved ejection fraction occur along with diastolic function worsening 85
Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function 84
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran 84
Left Atrial Strain in the Assessment of Diastolic Function in Heart Failure: A Machine Learning Approach 83
Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony. 83
Prognostic Value of Dynamic Changes in Pulmonary Congestion During Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction 83
Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction 83
Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction 82
Pre-existing type 2 diabetes is associated with increased all-cause death independently of echocardiographic predictors of poor prognosis only in ischemic heart disease 82
Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF 80
Improvement of myocardial performance (Tei) index closely reflects intrinsic improvement of cardiac function: assessment in revascularized hibernating myocardium. 77
Burden of Ventricular Arrhythmias in CRT-D and ICD Recipients with Recovered Left Ventricular Ejection Fraction: the Additive Role of Speckle Tracking Echocardiography. 76
Managing hyperkalemia in patients with heart failure on guideline-directed medical therapy: challenges and opportunities 75
Microcirculation in hypertension 75
Echocardiographic assessment of patient hemodynamics in heart failure 74
Combining echo and natriuretic peptides to guide heart failure care in the outpatient setting: A position paper 74
Non-cardiac factors for prediction of response to cardiac resynchronization therapy: The value of baseline, and of serial changes, in red cell distribution width 73
Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement 73
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality? 71
Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: a double-blind, placebo controlled crossover stress echocardiographic study. 71
Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients 70
Exercise elicits dynamic changes in extravascular lung water and haemodynamic congestion in heart failure patients with preserved ejection fraction 70
A strange case of Transthyretin Cardiac Amyloidosis in the Elderly: a diagnostic challenge 69
Correlazioni tra riserva contrattile e pattern di riempimento diastolico transmitralico nel miocardio ibernato. 69
[The NEAT-HFpEF study] 69
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 69
Association of non-cardiac comorbidities and sex with long-term Re-hospitalization for heart failure 68
Valore prognostico dei livelli ematici di BNP nello scompenso cardiaco: stratificazione prognostica basata sulla combinazione tra riduzione percentuale e valore assoluto del BNP alla dimissione 68
The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure. 68
Improvement in TEI Index closely mirrors reversal of left ventricular dysfunction in chronic ischemic cardiomyopathy. 68
Valore prognostico del BNP nello scompenso cardiaco: importanza del raggiungimento di uno stato di euvolemia. 67
Machine learning analysis of left ventricular function to characterize heart failure with preserved ejection fraction 67
Usefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapy 65
Commentary: Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: Physiology versus Empiricism 65
EFFETTI DELLA TERAPIA CRONICA CON NITRODERIVATI NEI PAZIENTI CON SINDROMI CORONARICHE ACUTE 64
Long term follow-up of acute coronary syndrome in patients with Metabolic Syndrome. 64
Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer 64
Do patients' and doctors' perceptions about cardiovascular outcomes coincide? A one-to-one survey at in-hospital and outpatient level 62
Valore prognostico del BNP nello scompenso cardiaco: confronto fra variazione percentuale dei livelli ematici dall'ingresso alla predimissione e valore assoluto in predimissione 61
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction 60
Il miglioramento del Tei-index rispecchia strettamente il recupero della disfunzione ventricolare sinistra in pazienti con cardiomiopatia ischemica cronica. 60
Relation between contractile riserve and diastolic function in hibernating myocardium. 59
Prognostic value of nt-probnp, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction 59
Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies 58
Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction 55
Left Atrio-ventricular Coupling Index: A Novel Diastolic Parameter to Refine Prognosis in Heart Failure 54
Reproducibility of echocardiographic assessment of 2D-derived longitudinal strain parameters in a population-based study (the STANISLAS Cohort study) 53
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 52
Prognostic role of left ventricular ejection fraction in heart failure: Back to the future? 52
Right Heart Remodeling and Outcomes in Patients With Tricuspid Regurgitation: A Literature Review and Meta-Analysis 52
Unraveling the relationship between serum uric acid levels and cardiovascular risk 51
Management of heart failure in the new era: The role of scores 51
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 50
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 49
Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score 49
BLITZ-HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines 48
Effects of SGLT2 inhibitors on cardiac structure and function 48
Different right ventricular dysfunction and pulmonary coupling in acute heart failure according to the left ventricular ejection fraction 47
Distinct role of minimal and maximal left atrial volumes in assessing LV filling pressures and prognosis in chronic heart failure 47
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY) 46
Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF 46
Non-invasive assessment of acute heart failure by Stevenson classification: Does echocardiographic examination recognize different phenotypes? 46
The Emerging Role of Left Atrioventricular Coupling Index (LACI) in Heart Failure: A New Frontier for CMR 46
Feasibility and Safety of a Three-Dimensional Sheath for Right Ventricular Septal Endomyocardial Biopsy 46
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 46
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry) 45
Totale 7.706
Categoria #
all - tutte 38.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021174 0 0 0 0 0 0 0 0 0 29 41 104
2021/2022756 19 110 9 55 27 10 10 229 21 71 92 103
2022/20231.235 86 227 10 139 96 123 6 49 450 8 32 9
2023/2024541 20 84 26 22 4 2 157 4 55 19 64 84
2024/20251.535 39 150 59 47 231 97 38 109 297 87 279 102
2025/20263.239 277 221 190 443 464 286 565 183 343 267 0 0
Totale 8.467